BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Condition:   Intermittent Claudication Interventions:   Drug: Cilostazol 100 mg;   Drug: PMR 135 mg Sponsor:   Genovate Biotechnology Co., Ltd., Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials

Home-based Exercice Therapy for Patients With Intermittent Claudication Using a New Smartphone Application
Condition:   Intermittent Claudication Interventions:   Other: E-REVA® app;   Other: No E-REVA® app Sponsor:   CHU de Reims Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials

A Randomized Clinical Trial for GNX80 in Intermittent Claudication
Condition:   Intermittent Claudication Interventions:   Drug: GNX80;   Drug: Placebo Sponsor:   SK Chemicals Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2022 Category: Research Source Type: clinical trials